Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Railcare Group | RAIL | Apr 30, 2024 | 28.90 | +2.12 |
Railway Metrics and Dynamics Sweden AB | RMDX | Apr 30, 2024 | 2.12 | 0.00 |
Raketech | RAKE | Apr 30, 2024 | 13.20 | -0.60 |
Rana Gruber ASA | RANAO | Apr 30, 2024 | 83.30 | +3.74 |
RanLOS | RLOSB | Apr 30, 2024 | 6.82 | 0.00 |
Ranplan Group | RPLAN | Apr 30, 2024 | 1.06 | 0.00 |
Ratos A | RATOA | Apr 30, 2024 | 40.70 | +0.74 |
Ratos B | RATOB | Apr 30, 2024 | 38.60 | +0.78 |
RaySearch Laboratories B | RAYB | Apr 30, 2024 | 120.60 | +1.17 |
Raytelligence | RAYTL | Apr 30, 2024 | 0.00 | 0.00 |
Readly International | READ | Apr 30, 2024 | 14.55 | 0.00 |
Real Fastigheter AB | REAL | Apr 30, 2024 | 8.48 | 0.00 |
RealFiction | REALFI | Apr 30, 2024 | 14.00 | 0.00 |
Recyctec B | RECYB | Apr 30, 2024 | 0.87 | +7.67 |
Rederi Gotland AB | GOTLA | Apr 30, 2024 | 1 990.00 | 0.00 |
Rederi Gotland AB. ser. B | GOTLB | Apr 30, 2024 | 1 990.00 | 0.00 |
Redsense Medical | REDS | Apr 30, 2024 | 8.10 | +1.25 |
Redwood Pharma | REDW | Apr 30, 2024 | 0.95 | +0.21 |
Refine Group | REFINE | Apr 30, 2024 | 2.48 | +5.98 |
Rejlers B | REJLB | Apr 30, 2024 | 141.00 | -2.89 |
Renewable Ventures Nordic | RVN | Apr 30, 2024 | 7.90 | +20.61 |
Rentunder Holding | RENT | Apr 30, 2024 | 0.28 | -6.00 |
Respiratorius | RESP | Apr 30, 2024 | 0.24 | -7.45 |
Resqunit | RESQ | Apr 30, 2024 | 0.80 | 0.00 |
Resurs Holding | RESURS | Apr 30, 2024 | 16.60 | +8.71 |
Revolutionrace | RVRC | Apr 30, 2024 | 62.90 | -0.16 |
RightBridge Ventures Group | RIGHTB | Apr 30, 2024 | 0.03 | +0.72 |
Rolling Optics Holding | RO | Apr 30, 2024 | 0.84 | +0.48 |
Rottneros | RROS | Apr 30, 2024 | 11.54 | -0.69 |
RugVista Group | RUG | Apr 30, 2024 | 66.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.